Effectiveness of Maternal Oral Glucose Intake in Improving Blood Glucose Levels in Hypoglycemic Neonates; A Randomized Controlled Trial.

IF 1 Q4 PHARMACOLOGY & PHARMACY
Bharat Pareek, Ramya Kundayi Ravi, Daljit Kaur, Rishu Thakur, Maria Mattu, Jyoti Shika
{"title":"Effectiveness of Maternal Oral Glucose Intake in Improving Blood Glucose Levels in Hypoglycemic Neonates; A Randomized Controlled Trial.","authors":"Bharat Pareek, Ramya Kundayi Ravi, Daljit Kaur, Rishu Thakur, Maria Mattu, Jyoti Shika","doi":"10.2174/0115748871393641250908074928","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Neonatal hypoglycemia, a common metabolic condition requiring prompt recognition, timely intervention, and careful monitoring to prevent adverse neurodevelopmental outcomes, can be effectively treated with glucose intake through breast milk, a simple and cost-effective approach. This study aimed to evaluate the effectiveness of oral glucose intake by nursing mothers in increasing blood glucose levels in hypoglycemic newborns.</p><p><strong>Methods: </strong>A parallel-group randomized control trial was conducted from July to August 2023 with 60 postnatal mothers and their newborns admitted to a government hospital in Punjab, India. Participants were randomly assigned to either the experimental or the control group using the concealed envelope method. Mothers in the experimental group received 35 g of oral glucose mixed with 200 ml of water once daily, whereas those in the control group received standard treatment. The outcome was assessed by measuring newborns' random blood glucose levels six hours post-intervention. The outcome assessors were blinded to the interventions. The study adhered to CONSORT guidelines, and statistical analysis was performed using mean, median, frequency, percentage, Chi-square, One-way ANOVA, and t-test.</p><p><strong>Results: </strong>The post-intervention mean ± SD random blood glucose levels were 61.77 ± 7.238 in the experimental group and 53.80 ± 5.081 in the control group, showing a statistically significant difference (p ≤0.001).</p><p><strong>Discussion: </strong>The results align with emerging evidence on maternal dietary influence on breast milk composition and neonatal health. However, limitations such as the small sample size and short-term outcome assessment necessitate further research to confirm and expand upon these findings.</p><p><strong>Conclusion: </strong>Oral glucose intake by lactating mothers significantly increased newborn blood glucose levels, demonstrating its effectiveness as a simple, noninvasive, and cost-effective intervention for neonatal hypoglycemia.</p><p><strong>Clinical trial registration number: </strong>CTRI -REF/2023/05/066900.</p>","PeriodicalId":21174,"journal":{"name":"Reviews on recent clinical trials","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on recent clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748871393641250908074928","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Neonatal hypoglycemia, a common metabolic condition requiring prompt recognition, timely intervention, and careful monitoring to prevent adverse neurodevelopmental outcomes, can be effectively treated with glucose intake through breast milk, a simple and cost-effective approach. This study aimed to evaluate the effectiveness of oral glucose intake by nursing mothers in increasing blood glucose levels in hypoglycemic newborns.

Methods: A parallel-group randomized control trial was conducted from July to August 2023 with 60 postnatal mothers and their newborns admitted to a government hospital in Punjab, India. Participants were randomly assigned to either the experimental or the control group using the concealed envelope method. Mothers in the experimental group received 35 g of oral glucose mixed with 200 ml of water once daily, whereas those in the control group received standard treatment. The outcome was assessed by measuring newborns' random blood glucose levels six hours post-intervention. The outcome assessors were blinded to the interventions. The study adhered to CONSORT guidelines, and statistical analysis was performed using mean, median, frequency, percentage, Chi-square, One-way ANOVA, and t-test.

Results: The post-intervention mean ± SD random blood glucose levels were 61.77 ± 7.238 in the experimental group and 53.80 ± 5.081 in the control group, showing a statistically significant difference (p ≤0.001).

Discussion: The results align with emerging evidence on maternal dietary influence on breast milk composition and neonatal health. However, limitations such as the small sample size and short-term outcome assessment necessitate further research to confirm and expand upon these findings.

Conclusion: Oral glucose intake by lactating mothers significantly increased newborn blood glucose levels, demonstrating its effectiveness as a simple, noninvasive, and cost-effective intervention for neonatal hypoglycemia.

Clinical trial registration number: CTRI -REF/2023/05/066900.

母亲口服葡萄糖对改善低血糖新生儿血糖水平的影响随机对照试验。
新生儿低血糖是一种常见的代谢疾病,需要及时识别、及时干预和仔细监测,以防止不良的神经发育结局。通过母乳摄入葡萄糖可以有效治疗新生儿低血糖,这是一种简单而经济的方法。本研究旨在评估哺乳母亲口服葡萄糖摄入对提高低血糖新生儿血糖水平的有效性。方法:对2023年7月至8月在印度旁遮普省一家政府医院住院的60名产后母亲及其新生儿进行平行组随机对照试验。采用隐信封法,将参与者随机分为实验组和对照组。实验组的母亲每天一次口服葡萄糖35 g与200 ml水混合,而对照组的母亲则接受标准治疗。干预六小时后,通过测量新生儿的随机血糖水平来评估结果。结果评估者对干预措施是不知情的。研究遵循CONSORT指南,采用均数、中位数、频率、百分比、卡方、单因素方差分析和t检验进行统计分析。结果:实验组干预后平均±SD随机血糖水平为61.77±7.238,对照组为53.80±5.081,差异有统计学意义(p≤0.001)。讨论:研究结果与新出现的关于母亲饮食对母乳成分和新生儿健康影响的证据一致。然而,样本量小和短期结果评估等局限性需要进一步的研究来证实和扩展这些发现。结论:哺乳期母亲口服葡萄糖可显著提高新生儿血糖水平,证明其作为一种简单、无创、经济有效的新生儿低血糖干预措施的有效性。临床试验注册号:CTRI -REF/2023/05/066900。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reviews on recent clinical trials
Reviews on recent clinical trials PHARMACOLOGY & PHARMACY-
CiteScore
3.10
自引率
5.30%
发文量
44
期刊介绍: Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信